Murepavadin Enhances the Killing Efficacy of Ciprofloxacin against <i>Pseudomonas aeruginosa</i> by Inhibiting Drug Efflux
<i>Pseudomonas aeruginosa</i> is a multidrug-resistant Gram-negative pathogen and one of the leading causes of ventilator-associated pneumonia and infections in patients with chronic obstructive pulmonary disease and cystic fibrosis. Murepavadin is a peptidomimetic that specifically targets outer-me...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2024-08-01
|
| Col·lecció: | Antibiotics |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2079-6382/13/9/810 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
